Figure 3From: Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study Mean and standard deviation of gene expression before and after ATO and Ascorbic Acid treatment of ICEBERG (A), TNFRSF1A (B) and BCL2L14 (C) in the whole series of patients. Back to article page